0001209191-20-065424.txt : 20201230 0001209191-20-065424.hdr.sgml : 20201230 20201230060012 ACCESSION NUMBER: 0001209191-20-065424 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201229 FILED AS OF DATE: 20201230 DATE AS OF CHANGE: 20201230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIGGINS MARK C CENTRAL INDEX KEY: 0001236540 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36818 FILM NUMBER: 201423970 MAIL ADDRESS: STREET 1: 12671 HIGH BLUFF DRIVE SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tracon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001394319 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4350 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 800 CITY: San Diego STATE: CA ZIP: 92122 BUSINESS PHONE: 858-550-0780 MAIL ADDRESS: STREET 1: 4350 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 800 CITY: San Diego STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: Tracon Pharmaceuticals Inc DATE OF NAME CHANGE: 20070324 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-29 0 0001394319 Tracon Pharmaceuticals, Inc. TCON 0001236540 WIGGINS MARK C C/O TRACON PHARMACEUTICALS, INC. 4350 LA JOLLA VILLAGE DRIVE SAN DIEGO CA 92122 0 1 0 0 Chief Business Officer Common Stock 2020-12-29 4 P 0 997 10.57 A 13697 D Common Stock 2020-12-29 4 P 0 3 10.56 A 13700 D Includes 350 shares acquired by the reporting person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2020. /s/ Scott B. Brown, Attorney-in-Fact 2020-12-30